CSC or cancer stem cells are cancerous cell possessing stem cell characteristics with respect to proliferate and potential of producing further cancer cells. CSC has unique capability of generating tumors by itself being a separate entity in tumor and simultaneously destructing the existing tumor. Therefore, increased R&D in the field of CSC centered therapeutics is expected to enhance survival chances and life quality in metastatic cancer patients. According to a report published by W.H.O cancer fatalities are expected to increase from 14 million in 2012 to 22 million in 2020. Increasing prevalence rate of cancer clubbed with increasing fatalities due to cancer across the globe is compelling researchers to find novel prognostic tools for the same. Early prognosis helps to decide course of treatment for cancer. Owing to successful implementation of CSC as a therapeutic tool in animals, cancer stem cells human testing is in its developmental phase. Ethical issues and stringent regulations are hindering its growth rate.
According to the report published by W.H.O, 8.2 million deaths worldwide were due to cancer, colorectal cancer constituted 8.4%, breast cancer constituted 6.0% and liver constituted 9.0% in 2012. Increasing burden of cancer mortality is fueling cancer research activities. CSC is being studied with respect to different types of cancers such as breast cancer, lung cancer, skin cancer, colorectal cancer and bone cancer. Key growth drivers for Cancer stem cells market are government initiatives pertaining to cancer research clubbed with research funding for the same. On the contrary, ethical issues related to CSC research and rigid human trials norms are few of the growth restraining factors of CSC market.
Cancer stem cells market is divided into four main geographies such as Europe, North America, Asia Pacific and RoW. With virtue of technological advancements and enhanced healthcare infrastructure North America holds the upper hand in worldwide cancer stem cells market. Asia Pacific region is expected to grow at a lucrative rate during the forecast period due to the rapidly improving healthcare facilities, increase in prevalence of cancer, increasing healthcare expenditure levels, upsurge in research and development activities related to cancer and increasing patient awareness in the emerging markets of India and China. Some key market players include AVIVA BioSciences Corporation, AdnaGen AG, Advanced Cell Diagnostics Inc., Silicon Biosystems S.p.A, Vitatex Inc. and Veridex, LLC
Avail customized purchase options to meet your research needs:
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.